Harmony Biosciences Files Proxy Statement for Annual Meeting

TL;DR

Harmony Bio proxy filed for May 29th meeting - shareholders vote on company matters.

AI Summary

Harmony Biosciences Holdings, Inc. filed a definitive proxy statement (DEF 14A) on April 11, 2024, for its annual meeting on May 29, 2024. The filing concerns the solicitation of proxies from shareholders regarding matters to be voted on at the meeting. Harmony Biosciences is a pharmaceutical company focused on treatments for rare diseases.

Why It Matters

This filing provides shareholders with crucial information about the company's governance and proposals to be voted on, impacting their ability to make informed decisions about the company's future direction.

Risk Assessment

Risk Level: low — A DEF 14A filing is a routine disclosure document for shareholder meetings and does not inherently present new financial risks.

Key Players & Entities

• Harmony Biosciences Holdings, Inc. (company) — Registrant
• 0001140361-24-019230 (filing_id) — Accession Number
• 20240411 (date) — Filing Date
• 20240529 (date) — Meeting Date

FAQ

From the Filing

0001140361-24-019230.txt : 20240411 0001140361-24-019230.hdr.sgml : 20240411 20240411081708 ACCESSION NUMBER: 0001140361-24-019230 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 26 CONFORMED PERIOD OF REPORT: 20240529 FILED AS OF DATE: 20240411 DATE AS OF CHANGE: 20240411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 24837180 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 DEF 14A 1 ny20020531x1_def14a.htm DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ ​ ​ Filed by a Party other than the Registrant   ☐ Check the appropriate box:   ☐ Preliminary Proxy Statement   ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement   ☐ Definitive Additional Materials   ☐ Soliciting Material Pursuant to   ☐ 240.14a-11(c) or   ☐ 240.14a-2 Harmony Biosciences Holdings, Inc. (Name of Registrant as Specified In Its Charter) Payment of Filing Fee (Check the appropriate box): ☒ ​ ​ No fee required.   ☐ ​ ​ Fee paid previously with preliminary materials.   ☐ ​ ​ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. TABLE OF CONTENTS   HARMONY BIOSCIENCES HOLDINGS, INC. 630 W. GERMANTOWN PIKE, SUITE 215 PLYMOUTH MEETING, PENNSYLVANIA 19462 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To Be Held at 1:00 p.m. Eastern Time on May 29, 2024 via online webcast at www.virtualshareholdermeeting.com/HRMY2024. Dear Stockholders of Harmony Biosciences Holdings, Inc.: The 2024 annual meeting of stockholders (the “Annual Meeting”) of Harmony Biosciences Holdings, Inc., a Delaware corporation (“Harmony”), will be held virtually on May 29, 2024 at 1:00 p.m. Eastern Time . The Annual Meeting will be a virtual meeting of stockholders, which will be conducted via live audio webcast at www.virtualshareholdermeeting.com/HRMY2024. We believe that a virtual meeting provides expanded access, improved communication and cost savings for our stockholders and Harmony. Stockholders will be able to attend and listen to the Annual Meeting live, submit questions and vote their shares electronically at the Annual Meeting from virtually any location around the world. In order to attend and vote at the Annual Meeting, please follow the instructions in “Questions and Answers About the Proxy Materials and Our Annual Meeting: What do I need to do to attend the Annual Meeting virtually?” on page 3 . We are holding the Annual Meeting for the following purposes, as more fully described in the accompanying proxy statement: 1. to elect three Class I directors to serve until our 2027 annual meeting of stockholders and until their successors are duly elected and qualified; 2. to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024; and 3. to transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof. Our board of directors has fixed the close of business on April 1, 2024 as the record date